Home > Financial Ratios > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) 0.37-16.3434.26136.36-34.58

What is the latest EBIT Growth ratio of EMCURE PHARMACEUTICALS ?

The latest EBIT Growth ratio of EMCURE PHARMACEUTICALS is 0.37 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar20240.37
Mar2023-16.34
Mar202234.26
Mar2021136.36
Mar2020-34.58

How is EBIT Growth of EMCURE PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2024 0.37
Positive
Mar2023 -16.34
Negative
Mar2022 34.26
-74.88
Mar2021 136.36
Positive
Mar2020 -34.58 -

Other Financial Ratios of EMCURE PHARMACEUTICALS


Compare EBIT Growth ratio of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹18,700.8 Cr -8% 4.7% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹410,142.0 Cr -1.5% 9.1% 9.1% Stock Analytics
DIVIS LABORATORIES ₹145,762.0 Cr -4.9% -0.6% 59.1% Stock Analytics
CIPLA ₹114,322.0 Cr -1.8% 1% 0.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹111,171.0 Cr 1.6% 12.1% 21.8% Stock Analytics
DR REDDYS LABORATORIES ₹92,603.7 Cr -3% -0.9% -7.7% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

-8%

4.7%

NA
SENSEX

-2.9%

3.1%

1.8%


You may also like the below Video Courses